{
  "pmcid": "11764675",
  "sha256": "5ef85c23239cc7a89cab1f120a9172c6b56082c7bf84b2a1e351cab1abb40b9c",
  "timestamp_utc": "2025-11-09T15:23:25.310500+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.71685064935065,
    "reading_ease": 31.005990259740287,
    "word_count": 308
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "25 patients who underwent EVLA from April 2022 to June 2023 at the Hospital das Clínicas de Pernambuco/UFPE"
      },
      "Intervention": {
        "score": 2,
        "evidence": "This study evaluates hemodynamic and anatomic changes in great saphenous vein (GSV) tributaries after endovenous laser ablation (EVLA)."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: This study evaluates hemodynamic and anatomic changes in great saphenous vein (GSV) tributaries after endovenous laser ablation (EVLA)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "All patients were evaluated by Doppler ultrasound preoperatively and 3 months after the surgical treatment."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "This case series analyzed 112 areas in 28 lower limbs of 25 patients who underwent EVLA from April 2022 to June 2023"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The results included 28 lower limbs from 23 patients"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Ninety days after EVLA, all treated GSVs were occluded. The average diameter of GSV decreased in all four regions studied: saphenous-femoral junction, medium thigh, knee, and medium leg ( P ≤ .001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}